War of words erupts over 'slow' Fisons
Sunday 20 August 1995
The allegation brought a stinging riposte from the Fisons camp. One highly placed source there claimed it was RPR, not Fisons, which had dragged its feet over a joint venture between the two companies in Europe.
RPR said Fisons was incapable of delivering on its planned strategy of growing by acquisition, licensing deals and other joint ventures because suitable deals were hard to find and Fisons was slow to negotiate them. Rob Cawthorn, chairman of RPR, said "very long discussions" were "one of the hallmarks of dealing with Fisons".
His chief executive, Michel de Rosen, said: "We've done dozens of deals, but Fisons has been, of all the companies we dealt with, the slowest."
Fisons reacted angrily. One source said he found it "staggering" that RPR could attack Fisons when only a few months earlier the company had had to complain about RPR's dilatoriness in a memo to Mr Cawthorn.
As the battle of words erupted, Fisons was trying to drum up a contested auction for itself. It and its merchant bank adviser, SBC Warburg, hope to attract a white knight to start a bidding war. According to the Fisons source: "We don't have any hang-ups about selling. The issue is very much price. RPR's pounds 2.40 offer is totally inadequate."
The source continued: "We've had a huge number of calls. I would expect a lot of companies over the next few days will be thinking very hard."
Zeneca, Merck, Astra, Ciba-Geigy, Sandoz and Schering Plough were all mooted as possible white knights. But the consensus among analysts is that none will actually step in.
Alex Isaac, drugs analyst with stockbroker Panmure Gordon, said a counter- bid was unlikely, although Fisons would try to talk up the price.
The company might be able to wrest an extra 20p a share from RPR, but the price was fairly full, another analyst said. It looked fair compared with other recent drugs deals. Moreover, Fisons ought to be more lowly valued because it had no research and development arm and no "pipeline" of future products.
Mr Cawthorn was sceptical about white knights coming in: "Will they? At higher than this price? We'll see."
Mr de Rosen accused the Fisons chief executive, Stuart Wallis, of underestimating the difficulty of clinching deals with other drugs companies: "It's much easier to sell a business than to buy a business, especially in pharmaceuticals."
Mr Wallis is credited with doing a good job of slimming Fisons down to its core business of drug sales and marketing. But stage two of the strategy - growing the drugs business with joint ventures and acquisitions - has barely begun. "It's unfortunate they've been caught with their pants down,'' said Ms Isaac of Panmure Gordon.
- 1 Lord Sewel quits: Peer 'boasts of having sex with BBC presenter and seeing 13 mistresses'
- 2 Topshop pulls 'ridiculously skinny' mannequins after being shamed by customer on Facebook
- 3 Five-year-old boy forced classmate to simulate oral sex at primary school, claims mother
- 4 Black and ethnic minority people twice as likely to be hit by Tory cuts than white people, report finds
- 5 Polish court orders bank to repay drugged man after he spends £23,400 in lap dance bar
Mystery over deaths of 3,000 Napoleonic soldiers in mass grave has been solved
Boris Johnson apologises after giving his wife a 'backie' on his bike on the streets of London
Black and ethnic minority people twice as likely to be hit by Tory cuts than white people, report finds
Labour leadership: New poll shows party is now even 'less electable' than under Ed Miliband
Denmark bans kosher and halal slaughter as minister says ‘animal rights come before religion’
The 9 charts that show the 'left-wing' policies of Jeremy Corbyn the public actually agrees with
Labour leadership contender Jeremy Corbyn says 'we can learn a great deal from Karl Marx'
The last thing Labour needs is a leader like Jeremy Corbyn who people want to vote for
What the Labour party could look like under Jeremy Corbyn
I am the Jeremy Corbyn supporter that many will tell you doesn't exist
Public anger after French sunbather beaten up by gang for wearing a bikini in Reims park
iJobs Money & Business
£22500 - £24500 per annum: Recruitment Genius: Inbound and outbound calls with...
£18000 - £40000 per annum: Recruitment Genius: This fast growing Insurance Bro...
£40 - 45k (DOE) + Benefits: Guru Careers: A Research Associate / Research Anal...
£90000 - £98000 per annum + benefits : Ashdown Group: A truly exciting opportu...